The role of endoplasmic reticulum stress in the regulation of long noncoding RNAs in cancer
- PMID: 35959643
- DOI: 10.1002/jcp.30846
The role of endoplasmic reticulum stress in the regulation of long noncoding RNAs in cancer
Abstract
Cancer cells must overcome a variety of external and internal stresses to survive and proliferate. These unfavorable conditions include the accumulation of mutations, nutrient deficiency, oxidative stress, and hypoxia. These stresses can cause aggregation of misfolded proteins inside the endoplasmic reticulum. Under these conditions, the cell undergoes endoplasmic reticulum stress (ER-stress), and consequently initiates the unfolded protein response (UPR). Activation of the UPR triggers transcription factors and regulatory factors, including long noncoding RNAs (lncRNAs), which control the gene expression profile to maintain cellular stability and hemostasis. Recent investigations have shown that cancer cells can ensure their survival under adverse conditions by the UPR affecting the expression of lncRNAs. Therefore, understanding the relationship between lncRNA expression and ER stress could open new avenues, and suggest potential therapies to treat various types of cancer.
Keywords: ER stress; cell survival; long noncoding RNAs; signaling pathways; unfolded protein response (UPR).
© 2022 Wiley Periodicals LLC.
Similar articles
-
Interplay between endoplasmic reticulum stress and non-coding RNAs in cancer.J Hematol Oncol. 2020 Dec 2;13(1):163. doi: 10.1186/s13045-020-01002-0. J Hematol Oncol. 2020. PMID: 33267910 Free PMC article. Review.
-
The transcriptional profiles and functional implications of long non-coding RNAs in the unfolded protein response.Sci Rep. 2018 Mar 21;8(1):4981. doi: 10.1038/s41598-018-23289-3. Sci Rep. 2018. PMID: 29563563 Free PMC article.
-
LncRNAs and CircRNAs in Endoplasmic Reticulum Stress: A Promising Target for Cardiovascular Disease?Int J Mol Sci. 2023 Jun 8;24(12):9888. doi: 10.3390/ijms24129888. Int J Mol Sci. 2023. PMID: 37373035 Free PMC article. Review.
-
The role of MAPK signalling pathways in the response to endoplasmic reticulum stress.Biochim Biophys Acta. 2014 Oct;1843(10):2150-63. doi: 10.1016/j.bbamcr.2014.01.009. Epub 2014 Jan 15. Biochim Biophys Acta. 2014. PMID: 24440275 Review.
-
Unfolded protein response activation compensates endoplasmic reticulum-associated degradation deficiency in Arabidopsis.J Integr Plant Biol. 2017 Jul;59(7):506-521. doi: 10.1111/jipb.12544. J Integr Plant Biol. 2017. PMID: 28418178
Cited by
-
A risk score model based on endoplasmic reticulum stress related genes for predicting prognostic value of osteosarcoma.BMC Musculoskelet Disord. 2023 Jun 23;24(1):519. doi: 10.1186/s12891-023-06629-x. BMC Musculoskelet Disord. 2023. PMID: 37353812 Free PMC article.
-
Plant-derived natural products and combination therapy in liver cancer.Front Oncol. 2023 Feb 14;13:1116532. doi: 10.3389/fonc.2023.1116532. eCollection 2023. Front Oncol. 2023. PMID: 36865794 Free PMC article. Review.
-
Acrylamide Induces Antiapoptotic Autophagy and Apoptosis by Activating PERK Pathway in SH-SY5Y Cells.Toxics. 2025 Jan 7;13(1):41. doi: 10.3390/toxics13010041. Toxics. 2025. PMID: 39853039 Free PMC article.
-
Single-cell RNA Sequencing Demonstrates the Heterogeneity of Different Molecular Subtypes in Gastric Cancer.Biochem Genet. 2024 Sep 23. doi: 10.1007/s10528-024-10922-2. Online ahead of print. Biochem Genet. 2024. PMID: 39311993
-
Endoplasmic reticulum stress related IncRNA signature predicts the prognosis and immune response evaluation of uterine corpus endometrial carcinoma.Front Oncol. 2023 Jan 4;12:1064223. doi: 10.3389/fonc.2022.1064223. eCollection 2022. Front Oncol. 2023. PMID: 36686816 Free PMC article.
References
REFERENCES
-
- Alasiri, G., Jiramongkol, Y., Zona, S., Fan, L. Y.-N., Mahmud, Z., Gong, G., Lee, H. J., & Lam, E. W.-F. (2019). Regulation of PERK expression by FOXO3: A vulnerability of drug-resistant cancer cells. Oncogene, 38(36), 6382-6398.
-
- Araki, K., & Nagata, K. (2011). Protein folding and quality control in the ER. Cold Spring Harbor Perspectives in Biology, 3(11), a007526.
-
- Axten, J. M., Medina, J. S. R., Feng, Y., Shu, A., Romeril, S. P., Grant, S. W., Li, W. H. H., Heerding, D. A., Minthorn, E., & Mencken, T. (2012). Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl) phenyl] acetyl}-2,3-dihydro-1 H-indol-5-yl)-7H-pyrrolo [2, 3-d] pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). Journal of Medicinal Chemistry, 55(16), 7193-7207.
-
- Axten, J. M., Romeril, S. P., Shu, A., Ralph, J., Medina, J. R., Feng, Y., Li, W. H. H., Grant, S. W., Heerding, D. A., & Minthorn, E. (2013). Discovery of GSK2656157: An optimized PERK inhibitor selected for preclinical development. ACS Medicinal Chemistry Letters, 4(10), 964-968.
-
- Bagratuni, T., Wu, P., Gonzalez de Castro, D., Davenport, E. L., Dickens, N. J., Walker, B. A., Boyd, K., Johnson, D. C., Gregory, W., & Morgan, G. J. (2010). XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments. Blood, 116(2), 250-253.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical